Belgium - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use
Since 2014, Belgium Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use jumped by 1.1% year on year. With 100.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 6 among other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use. Belgium is overtaken by Portugal, which was number 5 with 103 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Luxembourg with 89.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands ranked the highest with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, a growth of 3.9% compared to 2018. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada recorded the best 5 years average growth at +11.3% per year, while Austria was the worst growing country at -14% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 100.60 |
| 2018 | 97.20 |
| 2017 | 92.60 |
| 2016 | 108.70 |
| 2015 | 100.10 |
How does Belgium rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Netherlands
|
132 | 2019 | +3.9 % | +3.5 % | View data | |
| 2 |
#2
Spain
|
129 | 2019 | +2.8 % | +0.6 % | View data | |
| 5 |
#5
Portugal
|
103 | 2019 | +10.5 % | +2.2 % | View data | |
| 6 |
#6
Belgium
|
101 | 2019 | +3.5 % | +1.1 % | View data | |
| 7 |
#7
Luxembourg
|
89 | 2019 | +0.5 % | +0.9 % | View data | |